Analysis shows a 2.9% annual decline in occupational asthma with better control of mouse allergens, suggesting improved health outcomes.
Occupational asthma (OA) and rhinitis are health problems occurring in facilities employing animals for medical and scientific reasons. We have compared the UK trends (2006–2023) in these outcomes reported to the SWORD scheme with changes in routine and personal air monitoring for the major mouse (Mus m 1) and rat (Rat n 1) allergens. The exposure data contained 1540 and 688 mouse and rat results, respectively, expressed in ng.m−3. The median, 75th and 90th percentiles were used as exposure characteristics, and annually incrementing three-yearly rolling data slices compared exposure and health outcomes by linear regression. The median, P75 and P90 for Mus m 1 all showed annual declines of around 5–6% (p < 0.001), suggesting general improvements in controlling mouse allergen exposure, but without evidence of a decline in rat allergen levels (p > 0.05), although control measures for both species are largely identical. An annual mean decline in OA of 2.9% (p = 0.021) was identified, but without a significant decline in rhinitis (−1.4%; p = 0.21). Over 16 years, reductions in exposure to the predominant rodent species were accompanied by a concomitant but smaller reduction in OA. These data confirm the immediate value of controlling relevant allergen exposure in reducing the incidence of IgE-E mediated OA.
No takes yet. Share an insight, caveat, or question.
Mason et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: